Rapamycin

Repurposing generics for rare diseases
Drug development is a business, and those who synthesize new compounds often do so for large populations to maximize payoff. Unfortunately, this means that very rare diseases are often not the focus of major pharmaceutical company drug development. However, utilizing drugs that have been on the market for decades can help […]